Phosphodiesterase 4 inhibitors and db-cAMP inhibit TNF-α release from human mononuclear cells. Effects of cAMP and cGMP-dependent protein kinase inhibitors
We investigated the effects of specific inhibitors of cAMP-dependent protein kinase (PKA) and cGMP-dependent protein kinase (PKG) on the inhibitory activity of phosphodiesterase (PDE) type 4 inhibitors and of the cell permeable analogue of cAMP, db-cAMP on LPS-induced TNF-α release from human mononu...
Main Authors: | A. Hichami, E. Boichot, N. Germain, E. Berdyshev, O. Coqueret, V. Lagente |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1996-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/S0962935196000580 |
Similar Items
-
Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II.
by: Walid Mokni, et al.
Published: (2010-01-01) -
Development and application of fluorescent cAMP und cGMP biosensors
by: Nikolaev, Viacheslav
Published: (2005) -
Biophysical Techniques for Detection of cAMP and cGMP in Living Cells
by: Viacheslav O. Nikolaev, et al.
Published: (2013-04-01) -
Upregulation of Phosphodiesterase 2A Augments T Cell Activation by Changing cGMP/cAMP Cross-Talk
by: Roberta Kurelic, et al.
Published: (2021-10-01) -
IL-4 induces cAMP and cGMP in human monocytic cells
by: B. Dugas, et al.
Published: (1995-01-01)